Cite
HARVARD Citation
Lapointe, R. et al. (n.d.). Immune biomarker correlates from a Phase II study of ipilimumab (IPI) with carboplatin and paclitaxel (CP) in patients with unresectable stage III or IV metastatic melanoma (MM). Journal for immunotherapy of cancer. p. . [Online].